This company has been marked as potentially delisted and may not be actively trading. Zynerba Pharmaceuticals (ZYNE) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Zynerba Pharmaceuticals Short Interest DataZynerba Pharmaceuticals (ZYNE) has a short interest of 5.09 million shares, representing 25.51% of the float (the number of shares available for trading by the public). This marks a -4.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 515,333 shares to cover all short positions.Current Short Interest5,090,000 sharesPrevious Short Interest5,330,000 sharesChange Vs. Previous Month-4.50%Dollar Volume Sold Short$6.62 millionShort Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2023Outstanding Shares53,939,000 sharesFloat Size19,950,000 sharesShort Percent of Float25.51%Today's Trading Volume0 sharesAverage Trading Volume515,333 sharesToday's Volume Vs. Average0% Short Selling Zynerba Pharmaceuticals? Sign up to receive the latest short interest report for Zynerba Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZYNE Short Interest Over TimeZYNE Days to Cover Over TimeZYNE Percentage of Float Shorted Over Time Zynerba Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20235,090,000 shares $6.62 million -4.5%25.5%0 $1.30 10/15/20235,330,000 shares $6.93 million +1,169.1%25.2%0 $1.30 9/30/2023420,000 shares $535.50 thousand +80.9%N/A0.4 $1.28 9/15/2023232,200 shares $322.76 thousand -3.5%N/A0.2 $1.39 8/31/2023240,600 shares $320.00 thousand +286.8%N/A0.3 $1.33 8/15/202362,200 shares $83.97 thousand +52.8%N/A0.1 $1.35 7/31/202340,700 shares $14.86 thousand -52.0%N/A0.2 $0.37 7/15/202384,800 shares $28.84 thousand -45.2%N/A0.4 $0.34 6/30/2023154,700 shares $50.43 thousand +226.4%N/A0.8 $0.33 6/15/202347,400 shares $16.59 thousand -41.2%N/A0.3 $0.35 Get the Latest News and Ratings for ZYNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zynerba Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/31/202380,600 shares $26.92 thousand -4.5%N/A0.4 $0.33 5/15/202384,400 shares $30.30 thousand -7.1%N/A0.4 $0.36 4/30/202390,800 shares $34.87 thousand -49.6%N/A0.4 $0.38 4/15/2023180,300 shares $73.90 thousand +3.9%N/A0.6 $0.41 3/31/2023173,500 shares $74.61 thousand -27.1%N/A0.6 $0.43 3/15/2023238,000 shares $98.77 thousand +30.8%N/A0.7 $0.42 2/28/2023181,900 shares $84.04 thousand -0.8%N/A0.6 $0.46 2/15/2023183,300 shares $99.50 thousand +141.2%N/A0.6 $0.54 1/31/202376,000 shares $50.92 thousand +23.6%N/A0.2 $0.67 1/15/202361,500 shares $36.29 thousand -65.2%N/A0.2 $0.59 12/30/2022176,700 shares $93.65 thousand -68.6%N/A0.7 $0.53 12/15/2022562,600 shares $326.70 thousand -21.5%N/A2 $0.58 11/30/2022716,200 shares $384.81 thousand +23.2%N/A2.3 $0.54 11/15/2022581,400 shares $371.98 thousand +37.6%N/A1.8 $0.64 10/31/2022422,500 shares $308.47 thousand -20.0%N/A1.2 $0.73 10/15/2022528,200 shares $362.13 thousand -13.8%N/A1.3 $0.69 9/30/2022612,900 shares $448.64 thousand -23.5%N/A1.4 $0.73 9/15/2022800,900 shares $889.00 thousand +11.2%N/A1.8 $1.11 8/31/2022720,500 shares $842.99 thousand +8.0%N/A1.2 $1.17 8/15/2022667,400 shares $907.66 thousand -24.2%N/A1.1 $1.36 7/31/2022880,400 shares $1.00 million +7.1%N/A1.6 $1.14 7/15/2022822,300 shares $937.42 thousand -12.3%N/A1.6 $1.14 6/30/2022937,900 shares $1.07 million -0.9%N/A2 $1.14 6/15/2022946,000 shares $1.06 million +11.1%N/A1.9 $1.12 5/31/2022851,500 shares $815.74 thousand -5.5%N/A1.8 $0.96 5/15/2022901,300 shares $771.51 thousand -33.2%N/A2.7 $0.86 4/30/20221,350,000 shares $1.90 million No ChangeN/A4 $1.41 4/15/20221,350,000 shares $2.31 million -0.7%3.3%3.1 $1.71 3/31/20221,360,000 shares $2.79 million -20.0%3.3%2.7 $2.05 3/15/20221,700,000 shares $3.11 million -5.6%4.1%3.1 $1.83"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 2/28/20221,800,000 shares $4.07 million -6.3%4.4%3.1 $2.26 2/15/20221,920,000 shares $5.43 million -8.1%4.8%2.7 $2.83 1/31/20222,090,000 shares $5.45 million -24.3%5.2%2.1 $2.61 1/15/20222,760,000 shares $7.26 million -12.1%6.9%2.5 $2.63 12/31/20213,140,000 shares $9.04 million +4.7%7.9%2.5 $2.88 12/15/20213,000,000 shares $9.90 million +14.9%7.5%2.3 $3.30 11/30/20212,610,000 shares $9.03 million +9.7%6.5%1.8 $3.46 11/15/20212,380,000 shares $10.23 million +2.2%6.0%1.3 $4.30 10/29/20212,330,000 shares $8.92 million +13.7%5.8%1.2 $3.83 10/15/20212,050,000 shares $8.32 million +9.0%5.1%1.1 $4.06 9/30/20211,880,000 shares $7.97 million -1.6%4.7%1.1 $4.24 9/15/20211,910,000 shares $8.31 million +3.2%4.8%1.2 $4.35 8/31/20211,850,000 shares $8.20 million +1.1%4.6%1.2 $4.43 8/13/20211,830,000 shares $7.48 million -8.5%4.6%1.2 $4.09 7/30/20212,000,000 shares $8.82 million -2.9%5.0%1.6 $4.41 7/15/20212,060,000 shares $9.68 million -7.6%5.1%1.6 $4.70 6/30/20212,230,000 shares $11.80 million -14.6%5.6%1.6 $5.29 6/15/20212,610,000 shares $14.17 million +12.0%6.5%1.7 $5.43 5/28/20212,330,000 shares $13.23 million -35.5%5.8%1.3 $5.68 5/14/20213,610,000 shares $15.49 million +3.1%N/A2.1 $4.29 4/30/20213,500,000 shares $16.07 million +50.9%N/A1 $4.59 4/15/20212,320,000 shares $10.05 million -7.6%N/A0.4 $4.33 3/31/20212,510,000 shares $11.80 million -23.7%N/A0.5 $4.70 3/15/20213,290,000 shares $15.50 million +10.0%N/A0.6 $4.71 2/26/20212,990,000 shares $13.34 million -6.6%N/A0.6 $4.46 2/12/20213,200,000 shares $19.55 million -22.5%N/A0.7 $6.11 1/29/20214,130,000 shares $14.62 million -0.7%N/A1.2 $3.54 1/15/20214,160,000 shares $15.18 million -1.7%N/A4.3 $3.65 12/31/20204,230,000 shares $14.04 million +11.6%N/A4.9 $3.32 12/15/20203,790,000 shares $15.27 million -2.3%N/A5.4 $4.03 11/30/20203,880,000 shares $17.89 million +4.6%N/A6.9 $4.61 10/30/20204,370,000 shares $14.99 million +0.9%N/A8.4 $3.43 10/15/20204,330,000 shares $15.46 million -1.1%N/A7.7 $3.57 9/30/20204,380,000 shares $14.50 million +11.5%N/A7.2 $3.31 9/15/20203,930,000 shares $14.03 million -9.2%N/A3.1 $3.57 8/31/20204,330,000 shares $16.37 million -15.4%N/A3 $3.78 8/14/20205,120,000 shares $19.30 million -6.6%N/A3.1 $3.77 7/31/20205,480,000 shares $20.55 million -9.9%N/A3 $3.75 7/15/20206,080,000 shares $20.73 million -13.3%N/A3.4 $3.41 ZYNE Short Interest - Frequently Asked Questions What is Zynerba Pharmaceuticals' current short interest? Short interest is the volume of Zynerba Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 5,090,000 shares of ZYNE short. 25.51% of Zynerba Pharmaceuticals' shares are currently sold short. Learn More on Zynerba Pharmaceuticals' current short interest. What is a good short interest percentage for Zynerba Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.51% of Zynerba Pharmaceuticals' floating shares are currently sold short. Is Zynerba Pharmaceuticals' short interest increasing or decreasing? Zynerba Pharmaceuticals saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 5,090,000 shares, a decrease of 4.5% from the previous total of 5,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Zynerba Pharmaceuticals' float size? Zynerba Pharmaceuticals currently has issued a total of 53,939,000 shares. Some of Zynerba Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zynerba Pharmaceuticals currently has a public float of 19,950,000 shares. How does Zynerba Pharmaceuticals' short interest compare to its competitors? 25.51% of Zynerba Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Zynerba Pharmaceuticals: 2seventy bio, Inc. (5.37%), Acelyrin, Inc. (4.87%), Procaps Group S.A. (0.12%), OptiNose, Inc. (1.68%), PyroGenesis Canada Inc. (0.11%), Aadi Bioscience, Inc. (6.58%), Actinium Pharmaceuticals, Inc. (4.88%), Eagle Pharmaceuticals, Inc. (0.46%), Marinus Pharmaceuticals, Inc. (3.95%), Allakos Inc. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Corporation ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Corporation ($2.81 billion), lululemon athletica inc. ($2.35 billion), Tractor Supply Company ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings Inc. ($1.67 billion), and Newmont Corporation ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Zynerba Pharmaceuticals stock? Short selling ZYNE is an investing strategy that aims to generate trading profit from Zynerba Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Zynerba Pharmaceuticals? A short squeeze for Zynerba Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZYNE, which in turn drives the price of the stock up even further. How often is Zynerba Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZYNE, twice per month. The most recent reporting period available is October, 31 2023. More Short Interest Resources from MarketBeat Related Companies TSVT Short Squeeze SLRN Short Squeeze PROC Short Squeeze OPTN Short Squeeze PYRGF Short Squeeze AADI Short Squeeze ATNM Short Squeeze EGRX Short Squeeze MRNS Short Squeeze ALLK Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ZYNE) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynerba Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynerba Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
